search
Back to results

Interoceptive Exposure as a Treatment Option for Disabling Fear of Pain

Primary Purpose

Chronic Pain

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Interoceptive Exposure
Sponsored by
University of Leeds
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Presence of chronic pain (i.e. pain present for minimum of 3 months following tissue damage)
  • 18 years or older
  • Capacity to give informed consent
  • Appropriate diagnostic investigations in other specialties as appropriate have been exhausted and first line interventions, like analgesia, have been tried.
  • Participant has appropriate expectations regarding psychological treatment, i.e. does not expect injections etc.

Exclusion Criteria:

  • Insufficient understanding of English or additional needs which mean the potential participant is unable to complete questionnaires independently. This is because the research project does not have the resources to make significant adaptations to the materials i.e. translation into another language or into Braille.
  • Unable to meet the demands of the study (i.e. daily recording of data, daily practice of IE, coming for sessions to St James' Hospital).

Sites / Locations

  • Pain Clinic, Fielding House at St James's HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Pain Education/Interoceptive Exposure

Arm Description

This study will evaluate the effects of IE and will briefly comprises of: education session explaining the rationale behind IE practice, teaching of the technique, supervised IE practice and self-monitored home practice twice daily for the period of two weeks.

Outcomes

Primary Outcome Measures

Change in Daily Diary
The Daily Diary is a 9 item questionnaire used for recording daily ratings of pain distress, pain interference and the fear of pain. Items 1-4 use visual analogue scales (VAS) to measure pain distress and interference. Each VAS has two anchors: "not at all distressing" and "extremely distressing" for pain distress questions (Items 1-3) and "does not interfere" and "interferes completely" for pain interference (Item 4), providing a range of scores between 0 and 100. Higher scores indicate greater pain distress and interference. Additionally, there are 5 statements assessing the fear of pain, which participants rate on a 5 point Likert Scale, where the score of 0 equals "not at all" and score of 4 equals "all the time". An example question: "Pain Sensations are terrifying". Total Fear of Pain Score is calculated by adding up scores on items 5 to 9. Higher Scores indicate higher fear of pain, min = 0, max = 20.
Change in Activity levels, i.e. number of steps taken
This will be measured with an activity monitor NOKIA GO worn by participants on their wrists or attached to their belt.

Secondary Outcome Measures

Pain Catastrophising Scale (PCS: Sullivan, Bishop & Pivik, 1995)
Standardised measure of pain catastrophising. The PCS is a 13 item scale, with each item rated on a 5-point Likert type scale: 0 (Not at all) to 4 (all the time). Sample item: "I worry all the time about whether the pain will end". The PCS is broken into three sub-scales: magnification, rumination, and helplessness. Scores are added up for each sub-scale, a Total Score is achieved by adding up all 13 items. The higher the score, the more catastrophizing thoughts are present. Previous studies have shown a cutoff of more than 30 points to be associated with clinical relevance.
Pain Anxiety Symptoms Scale Short Scale (PASS-20: McCracken & Dhingra, 2002)
The PASS-20 assesses pain specific anxiety symptoms using four components of pain-related anxiety: cognitive, fear, escape avoidance, and physiological. Each of the four sub-scales has five items. All items are rated from 0 (never) to 5 (always). Sample item: "I worry when I am in pain". Scores are added up for each sub-scale, a Total Score is achieved by adding up all 20 items. The higher the score, the more pain anxiety symptoms. Maximum Total Score: 100, Minimum Total Score: 0.
Pain Disability Index (PDI: Pollard, 1984)
This is a brief self-report measure of disability and is designed to measure the extent to which chronic pain interferes with an individual's ability to engage in activities (Pollard, 1981). Respondents rate the degree to which pain interferes with functioning in seven broad areas: family/home responsibilities, recreation, social activity, occupation, sexual behaviour, self-care, and life-support activity on a ten-point scale of 0 (no disability) to 10 (total disability). Sample Item: "Recreation: This disability includes hobbies, sports, and other similar leisure time activities". An overall score (with a possible total of 70) is computed by summing the seven sub-scales, higher scores indicate greater level of pain related disability. Validity and reliability have been established for this measure (Tait, Chibnall and Krause, 1990).
Hospital Anxiety and Depression Scale (HADS: Zigmond & Snaith, 1983)
Standardised questionnaire used in assessing generalised anxiety and depression. The questionnaire comprises seven questions for anxiety and seven questions for depression (total number of items = 14). Each item on the questionnaire is scored from 0 - 3 and this means that a person can score between 0 and 21 for either anxiety or depression. Sample Item: "I feel tense or 'wound up'", response options: "Most of the time" (scored 3 points), "A lot of the time" (Scored 2 points), "From time to time" (Scored 1 point), "Not at all" (Scored 0 points). Although the anxiety and depression questions are interspersed within the questionnaire, they can be added up together (Total Score) or added up within each sub-scale (Depression Total Score and Anxiety Total Score). Higher scores are indicative of more symptoms of Generalised Anxiety and Depression.
Chronic Pain Acceptance Questionnaire (CPAQ: McCracken, Vowles & Eccleston, 2004)
Standardised questionnaire used in assessing the acceptance of pain in chronic pain sufferers. The CPAQ assesses acceptance of pain using two factors: Activity Engagement (participation in daily activities while acknowledging the presence of pain, 11 items) and Pain Willingness (the degree to which pain is allowed in experience without efforts to avoid or control it; 9 items). Sample Item: "My life is going well, even though I have chronic pain". The items on the CPAQ are rated on a 7-point scale from 0 (never true) to 6 (always true). Scoring is done by adding the items for Activity engagement and Pain willingness to obtain a Total Score for each factor. Additionally, a total score of Pain Acceptance is calculated by adding the scores for each factor together. Higher scores indicate higher levels of acceptance. Maximum Total Acceptance Score is 120, Minimum Total Acceptance Score is 0.

Full Information

First Posted
April 20, 2018
Last Updated
May 11, 2018
Sponsor
University of Leeds
search

1. Study Identification

Unique Protocol Identification Number
NCT03523637
Brief Title
Interoceptive Exposure as a Treatment Option for Disabling Fear of Pain
Official Title
Interoceptive Exposure as a Treatment Option for Disabling Fear of Pain: a Single Case Series
Study Type
Interventional

2. Study Status

Record Verification Date
May 2018
Overall Recruitment Status
Unknown status
Study Start Date
March 5, 2018 (Actual)
Primary Completion Date
September 30, 2018 (Anticipated)
Study Completion Date
September 30, 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Leeds

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to investigate the use of Interoceptive Exposure (IE) in treatment of disabling fear of pain using a single-case series design.
Detailed Description
The intervention Interoceptive Exposure (IE) is an exposure to bodily sensations used in treatment of variety of problems where body sensations are experienced as threatening. The application of IE is expected to reduce the threat value of pain and subsequently promote recovery. This study will evaluate the effects of IE and will briefly comprises of: education session explaining the rationale behind IE practice, teaching of the technique, supervised IE practice and self-monitored home practice twice daily for the period of two weeks. Depending on the length of baseline (i.e. observation period before the start of intervention) the study will last between 6 and 8 weeks. Daily Diary, a short nine item instrument was designed to measure the pain experience (intensity and interference) and fear of pain on a daily basis. Other, standard outcome measures include: pain related anxiety, pain catastrophising, pain related disability, knowledge about pain and general anxiety and depression. Study participants will be recruited during routine psychology screening assessment at the Pain Clinic at St James' Hospital. This study will recruit from clinical psychology waiting list patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Replicated experimental case series, also called replicated single-subject design or replicated single-case research design.
Masking
None (Open Label)
Allocation
N/A
Enrollment
8 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Pain Education/Interoceptive Exposure
Arm Type
Experimental
Arm Description
This study will evaluate the effects of IE and will briefly comprises of: education session explaining the rationale behind IE practice, teaching of the technique, supervised IE practice and self-monitored home practice twice daily for the period of two weeks.
Intervention Type
Behavioral
Intervention Name(s)
Interoceptive Exposure
Intervention Description
The intervention Interoceptive Exposure (IE) is an exposure to bodily sensations used in treatment of variety of problems where body sensations are experienced as threatening. This psychological technique is about focusing attention on pain, 'staying with the pain' without trying to escape it.
Primary Outcome Measure Information:
Title
Change in Daily Diary
Description
The Daily Diary is a 9 item questionnaire used for recording daily ratings of pain distress, pain interference and the fear of pain. Items 1-4 use visual analogue scales (VAS) to measure pain distress and interference. Each VAS has two anchors: "not at all distressing" and "extremely distressing" for pain distress questions (Items 1-3) and "does not interfere" and "interferes completely" for pain interference (Item 4), providing a range of scores between 0 and 100. Higher scores indicate greater pain distress and interference. Additionally, there are 5 statements assessing the fear of pain, which participants rate on a 5 point Likert Scale, where the score of 0 equals "not at all" and score of 4 equals "all the time". An example question: "Pain Sensations are terrifying". Total Fear of Pain Score is calculated by adding up scores on items 5 to 9. Higher Scores indicate higher fear of pain, min = 0, max = 20.
Time Frame
Assessed daily, throughout the duration of the study. Depending on the length of the baseline this will be between 42 and 56 days.
Title
Change in Activity levels, i.e. number of steps taken
Description
This will be measured with an activity monitor NOKIA GO worn by participants on their wrists or attached to their belt.
Time Frame
Assessed daily, throughout the duration of the study. Depending on the length of the baseline this will be between 42 and 56 days.
Secondary Outcome Measure Information:
Title
Pain Catastrophising Scale (PCS: Sullivan, Bishop & Pivik, 1995)
Description
Standardised measure of pain catastrophising. The PCS is a 13 item scale, with each item rated on a 5-point Likert type scale: 0 (Not at all) to 4 (all the time). Sample item: "I worry all the time about whether the pain will end". The PCS is broken into three sub-scales: magnification, rumination, and helplessness. Scores are added up for each sub-scale, a Total Score is achieved by adding up all 13 items. The higher the score, the more catastrophizing thoughts are present. Previous studies have shown a cutoff of more than 30 points to be associated with clinical relevance.
Time Frame
at three time points: assessment (day one), pre-intervention (depending on the length of the baseline 2 weeks, 3 weeks or 4 weeks later) and post-intervention (6, 7 or 8 weeks from the start of the intervention).
Title
Pain Anxiety Symptoms Scale Short Scale (PASS-20: McCracken & Dhingra, 2002)
Description
The PASS-20 assesses pain specific anxiety symptoms using four components of pain-related anxiety: cognitive, fear, escape avoidance, and physiological. Each of the four sub-scales has five items. All items are rated from 0 (never) to 5 (always). Sample item: "I worry when I am in pain". Scores are added up for each sub-scale, a Total Score is achieved by adding up all 20 items. The higher the score, the more pain anxiety symptoms. Maximum Total Score: 100, Minimum Total Score: 0.
Time Frame
at three time points: assessment (day one), pre-intervention (depending on the length of the baseline 2 weeks, 3 weeks or 4 weeks later) and post-intervention (6, 7 or 8 weeks from the start of the intervention).
Title
Pain Disability Index (PDI: Pollard, 1984)
Description
This is a brief self-report measure of disability and is designed to measure the extent to which chronic pain interferes with an individual's ability to engage in activities (Pollard, 1981). Respondents rate the degree to which pain interferes with functioning in seven broad areas: family/home responsibilities, recreation, social activity, occupation, sexual behaviour, self-care, and life-support activity on a ten-point scale of 0 (no disability) to 10 (total disability). Sample Item: "Recreation: This disability includes hobbies, sports, and other similar leisure time activities". An overall score (with a possible total of 70) is computed by summing the seven sub-scales, higher scores indicate greater level of pain related disability. Validity and reliability have been established for this measure (Tait, Chibnall and Krause, 1990).
Time Frame
at three time points: assessment (day one), pre-intervention (depending on the length of the baseline 2 weeks, 3 weeks or 4 weeks later) and post-intervention (6, 7 or 8 weeks from the start of the intervention).
Title
Hospital Anxiety and Depression Scale (HADS: Zigmond & Snaith, 1983)
Description
Standardised questionnaire used in assessing generalised anxiety and depression. The questionnaire comprises seven questions for anxiety and seven questions for depression (total number of items = 14). Each item on the questionnaire is scored from 0 - 3 and this means that a person can score between 0 and 21 for either anxiety or depression. Sample Item: "I feel tense or 'wound up'", response options: "Most of the time" (scored 3 points), "A lot of the time" (Scored 2 points), "From time to time" (Scored 1 point), "Not at all" (Scored 0 points). Although the anxiety and depression questions are interspersed within the questionnaire, they can be added up together (Total Score) or added up within each sub-scale (Depression Total Score and Anxiety Total Score). Higher scores are indicative of more symptoms of Generalised Anxiety and Depression.
Time Frame
at three time points: assessment (day one), pre-intervention (depending on the length of the baseline 2 weeks, 3 weeks or 4 weeks later) and post-intervention (6, 7 or 8 weeks from the start of the intervention).
Title
Chronic Pain Acceptance Questionnaire (CPAQ: McCracken, Vowles & Eccleston, 2004)
Description
Standardised questionnaire used in assessing the acceptance of pain in chronic pain sufferers. The CPAQ assesses acceptance of pain using two factors: Activity Engagement (participation in daily activities while acknowledging the presence of pain, 11 items) and Pain Willingness (the degree to which pain is allowed in experience without efforts to avoid or control it; 9 items). Sample Item: "My life is going well, even though I have chronic pain". The items on the CPAQ are rated on a 7-point scale from 0 (never true) to 6 (always true). Scoring is done by adding the items for Activity engagement and Pain willingness to obtain a Total Score for each factor. Additionally, a total score of Pain Acceptance is calculated by adding the scores for each factor together. Higher scores indicate higher levels of acceptance. Maximum Total Acceptance Score is 120, Minimum Total Acceptance Score is 0.
Time Frame
at three time points: assessment (day one), pre-intervention (depending on the length of the baseline 2 weeks, 3 weeks or 4 weeks later) and post-intervention (6, 7 or 8 weeks from the start of the intervention).

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Presence of chronic pain (i.e. pain present for minimum of 3 months following tissue damage) 18 years or older Capacity to give informed consent Appropriate diagnostic investigations in other specialties as appropriate have been exhausted and first line interventions, like analgesia, have been tried. Participant has appropriate expectations regarding psychological treatment, i.e. does not expect injections etc. Exclusion Criteria: Insufficient understanding of English or additional needs which mean the potential participant is unable to complete questionnaires independently. This is because the research project does not have the resources to make significant adaptations to the materials i.e. translation into another language or into Braille. Unable to meet the demands of the study (i.e. daily recording of data, daily practice of IE, coming for sessions to St James' Hospital).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Aleksandra Puchala
Phone
07925549965
Email
umapu@leeds.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Ciara Masterson, Dr
Phone
0113 343 8343
Email
C.Masterson@leeds.ac.uk
Facility Information:
Facility Name
Pain Clinic, Fielding House at St James's Hospital
City
Leeds
State/Province
West Yorkshire
ZIP/Postal Code
LS9 7TF
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vivienne Laidler, Dr
Phone
0113 206 5897
Email
vivienne.laidler@nhs.net
First Name & Middle Initial & Last Name & Degree
Aleksandra Puchala

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Interoceptive Exposure as a Treatment Option for Disabling Fear of Pain

We'll reach out to this number within 24 hrs